跳至主要内容
临床试验/NCT02027389
NCT02027389撤回不适用

Clinical and Economic Impact of a Rapid Test for Detection of Methicillin-resistant Staphylococcus Aureus (MRSA) From Sterile Sites (the Alere™ PBP2a)

Mayo Clinic1 个研究点 分布在 1 个国家开始时间: 2014年1月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
Mayo Clinic
试验地点
1
主要终点
Time (hours) to optimal antimicrobial therapy for patients with MSSA and MRSA infections in the pre-intervention and post-intervention periods

研究概览

简要总结

The objective of this study is to evaluate the impact of the Alere™ PBP2a test combined with pharmacist review of antimicrobial therapy, on clinical outcomes and cost in hospitalized patients with sterile site S. aureus infection.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Time (hours) to optimal antimicrobial therapy for patients with MSSA and MRSA infections in the pre-intervention and post-intervention periods

时间窗: within first 7 days of culture result

次要结局

  • Time (in hours) to identification of MRSA.(within first 3 days of culture result)
  • Vancomycin days of therapy following S. aureus culture result(during the 2 weeks following culture result)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ritu Banerjee, M.D., Ph.D.

Associate Professor

Mayo Clinic

研究点 (1)

Loading locations...

相似试验